Challenges in the diagnosis of insulin resistance: focusing on the role of HOMA-IR and Tryglyceride/glucose index

DL Tahapary, LB Pratisthita, NA Fitri, C Marcella… - Diabetes & Metabolic …, 2022 - Elsevier
Abstract Background and aims Metabolic Syndrome (MS) prevalence is increasing
worldwide in line with the growing prevalence of obesity. The underlying mechanism of MS …

Optimal cut-off values for the homeostasis model assessment of insulin resistance (HOMA-IR) and pre-diabetes screening: Developments in research and prospects …

Q Tang, X Li, P Song, L Xu - Drug discoveries & therapeutics, 2015 - jstage.jst.go.jp
Diabetes mellitus (DM) appears to be increasing rapidly, threatening to reduce life
expectancy for humans around the globe. The International Diabetes Federation (IDF) has …

Effects of exercise on NAFLD using non-targeted metabolomics in adipose tissue, plasma, urine, and stool

AF Babu, S Csader, V Männistö, MM Tauriainen… - Scientific Reports, 2022 - nature.com
The mechanisms by which exercise benefits patients with non-alcoholic fatty liver disease
(NAFLD), the most common liver disease worldwide, remain poorly understood. A non …

Insulin resistance in obesity and polycystic ovary syndrome: systematic review and meta-analysis of observational studies

S Behboudi-Gandevani… - Gynecological …, 2016 - Taylor & Francis
We aimed at investigating whether insulin resistance (IR)/sensitivity are impaired in
obese/non-obese polycystic ovary syndrome (PCOS) and obese/non-obese healthy …

Gender differences in cardiometabolic health and disease in a cross-sectional observational obesity study

C Strack, G Behrens, S Sag, M Mohr, J Zeller… - Biology of sex …, 2022 - Springer
Background Beyond the degree of adiposity, the pattern of fat distribution has a profound
influence on cardiometabolic risk. It is unclear if sex differences in body fat distribution can …

The association between the atherogenic index of plasma and cardiometabolic risk factors: a review

B Lioy, RJ Webb, F Amirabdollahian - Healthcare, 2023 - mdpi.com
Background: Metabolic syndrome (MetS) is a condition caused by a combination of
cardiometabolic risk factors (CMR). MetS leads to type 2 diabetes mellitus (T2DM) and …

Menstrual cycle irregularity and metabolic disorders: a population-based prospective study

M Rostami Dovom, F Ramezani Tehrani, S Djalalinia… - PLoS …, 2016 - journals.plos.org
The regularity of menstrual cycles is considered an indicator of women's reproductive health.
Previous studies with a cross-sectional design have documented the relationship between …

Trend of cardio-metabolic risk factors in polycystic ovary syndrome: a population-based prospective cohort study

F Ramezani Tehrani, SA Montazeri, F Hosseinpanah… - PLoS …, 2015 - journals.plos.org
Objective To see the changes of cardio-metabolic risk factors overtime in polycystic ovary
syndrome vs. control women. Methods This study was conducted on 637 participants (85 …

A comparison of the effects of oral contraceptives on the clinical and biochemical manifestations of polycystic ovary syndrome: a crossover randomized controlled trial

M Amiri, F Nahidi, R Bidhendi-Yarandi… - Human …, 2020 - academic.oup.com
STUDY QUESTION Do oral contraceptives (OCs) containing progestins with low androgenic
or antiandrogenic activities have different effects to those containing levonorgestrel (LNG) …

Evaluation of lipid ratios and triglyceride-glucose index as risk markers of insulin resistance in Iranian polycystic ovary syndrome women

A Kheirollahi, M Teimouri, M Karimi… - Lipids in health and …, 2020 - Springer
Background Insulin resistance has a vital role in the pathophysiology of polycystic ovary
syndrome (PCOS). Previous investigations have shown that some lipid ratios could be a …